215 related articles for article (PubMed ID: 27860186)
1. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
Russo MW; Steuerwald N; Norton HJ; Anderson WE; Foureau D; Chalasani N; Fontana RJ; Watkins PB; Serrano J; Bonkovsky HL
Liver Int; 2017 May; 37(5):757-764. PubMed ID: 27860186
[TBL] [Abstract][Full Text] [Related]
2. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
Krauskopf J; Caiment F; Claessen SM; Johnson KJ; Warner RL; Schomaker SJ; Burt DA; Aubrecht J; Kleinjans JC
Toxicol Sci; 2015 Feb; 143(2):268-76. PubMed ID: 25359176
[TBL] [Abstract][Full Text] [Related]
3. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.
Fontana RJ; Hayashi PH; Gu J; Reddy KR; Barnhart H; Watkins PB; Serrano J; Lee WM; Chalasani N; Stolz A; Davern T; Talwakar JA;
Gastroenterology; 2014 Jul; 147(1):96-108.e4. PubMed ID: 24681128
[TBL] [Abstract][Full Text] [Related]
4. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
[TBL] [Abstract][Full Text] [Related]
5. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
[TBL] [Abstract][Full Text] [Related]
6. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.
López-Riera M; Conde I; Castell JV; Jover R
Toxicol Sci; 2020 Feb; 173(2):229-243. PubMed ID: 31198949
[TBL] [Abstract][Full Text] [Related]
7. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
Kagawa T; Shirai Y; Oda S; Yokoi T
Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
[TBL] [Abstract][Full Text] [Related]
8. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
Steuerwald NM; Foureau DM; Norton HJ; Zhou J; Parsons JC; Chalasani N; Fontana RJ; Watkins PB; Lee WM; Reddy KR; Stolz A; Talwalkar J; Davern T; Saha D; Bell LN; Barnhart H; Gu J; Serrano J; Bonkovsky HL
PLoS One; 2013; 8(12):e81974. PubMed ID: 24386086
[TBL] [Abstract][Full Text] [Related]
9. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.
Shi Q; Yang X; Mendrick DL
Biomark Med; 2013 Apr; 7(2):307-15. PubMed ID: 23547824
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
Bonkovsky HL; Barnhart HX; Foureau DM; Steuerwald N; Lee WM; Gu J; Fontana RJ; Hayashi PJ; Chalasani N; Navarro VM; Odin J; Stolz A; Watkins PB; Serrano J;
PLoS One; 2018; 13(10):e0206389. PubMed ID: 30359443
[TBL] [Abstract][Full Text] [Related]
11. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
12. Serum proteomic profiling in patients with drug-induced liver injury.
Bell LN; Vuppalanchi R; Watkins PB; Bonkovsky HL; Serrano J; Fontana RJ; Wang M; Rochon J; Chalasani N;
Aliment Pharmacol Ther; 2012 Mar; 35(5):600-12. PubMed ID: 22403816
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Gastroenterology; 2019 Nov; 157(5):1245-1252.e3. PubMed ID: 31302142
[TBL] [Abstract][Full Text] [Related]
14. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury.
Hillman L; Gottfried M; Whitsett M; Rakela J; Schilsky M; Lee WM; Ganger D
Am J Gastroenterol; 2016 Jul; 111(7):958-65. PubMed ID: 27045922
[TBL] [Abstract][Full Text] [Related]
16. MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.
Howell LS; Ireland L; Park BK; Goldring CE
Expert Rev Mol Diagn; 2018 Jan; 18(1):47-54. PubMed ID: 29235390
[TBL] [Abstract][Full Text] [Related]
17. Latest advances in diagnosing and predicting DILI: what was new in 2017?
Barnhill MS; Real M; Lewis JH
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1033-1043. PubMed ID: 30111182
[TBL] [Abstract][Full Text] [Related]
18. Death and liver transplantation within 2 years of onset of drug-induced liver injury.
Hayashi PH; Rockey DC; Fontana RJ; Tillmann HL; Kaplowitz N; Barnhart HX; Gu J; Chalasani NP; Reddy KR; Sherker AH; Hoofnagle JH;
Hepatology; 2017 Oct; 66(4):1275-1285. PubMed ID: 28543844
[TBL] [Abstract][Full Text] [Related]
19. [The Correlation Between MicroRNAs in Serum and the Extent of Liver Injury].
Zuo YN; He XL; Shi XN; Wei SH; Yin HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):368-372. PubMed ID: 28616908
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury.
Yamaura Y; Tatsumi N; Takagi S; Tokumitsu S; Fukami T; Tajiri K; Minemura M; Yokoi T; Nakajima M
Clin Biochem; 2017 Dec; 50(18):1034-1039. PubMed ID: 28823616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
